Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis
- PMID: 11074539
- DOI: 10.1002/1096-8652(200011)65:3<223::aid-ajh8>3.0.co;2-9
Iron deficiency due to excessive therapeutic phlebotomy in hemochromatosis
Abstract
Thirteen adults (eight men, five women) with hemochromatosis had undergone routine iron depletion therapy but while on maintenance phlebotomies developed iron deficiency which persisted for 25 +/- 13 (mean +/- 1 SD) months before diagnosis. All had symptoms and signs of iron deficiency. Levels of transferrin saturation were 10% +/- 5% (1 SD), and serum ferritin concentrations were 8 +/- 3 ng/mL. Eleven had anemia; eight had hypochromia and microcytosis. Bone marrow specimens obtained in five patients revealed no stainable iron. Medical records indicated that parameters of body iron status were infrequently or incorrectly used for adjusting the frequency of phlebotomies. Two patients developed iron deficiency due to additional blood loss from esophageal varices and bilateral hip replacement, respectively. Ten of the patients were treated with ferrous sulfate, 325 mg daily, for 2-6 weeks when anemia was corrected. In patients who were not given iron, anemia and microcytosis recovered in 8-24 months. We conclude that (i) sustained iron deficiency in hemochromatosis patients should be prevented by monitoring hemoglobin levels and serum ferritin; and (ii) hemoglobin concentrations and values of mean corpuscular hemoglobin may be higher in iron-deficient persons with hemochromatosis than in individuals without hemochromatosis. Symptomatic iron deficiency in hemochromatosis patients may be treated safely with a brief course of ferrous sulfate. Recovery is slower when iron is not given. However, iron supplementation is unnecessary and not recommended for the mild, self-limited anemia and decreased serum iron and ferritin concentrations encountered after initial iron depletion therapy for hemochromatosis.
Similar articles
-
Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.Clin Chim Acta. 2005 Mar;353(1-2):61-6. doi: 10.1016/j.cccn.2004.10.001. Clin Chim Acta. 2005. PMID: 15698591
-
MCV as a guide to phlebotomy therapy for hemochromatosis.Transfusion. 2001 Jun;41(6):819-27. doi: 10.1046/j.1537-2995.2001.41060819.x. Transfusion. 2001. PMID: 11399827
-
Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.Am J Gastroenterol. 2003 Sep;98(9):2072-7. doi: 10.1111/j.1572-0241.2003.07292.x. Am J Gastroenterol. 2003. PMID: 14499790
-
[Hereditary hemochromatosis].Rev Gastroenterol Peru. 2001 Jan-Mar;21(1):42-55. Rev Gastroenterol Peru. 2001. PMID: 12170286 Review. Portuguese.
-
Management of hemochromatosis. Hemochromatosis Management Working Group.Ann Intern Med. 1998 Dec 1;129(11):932-9. doi: 10.7326/0003-4819-129-11_part_2-199812011-00003. Ann Intern Med. 1998. PMID: 9867745 Review.
Cited by
-
Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice.Physiol Rep. 2018 Sep;6(19):e13890. doi: 10.14814/phy2.13890. Physiol Rep. 2018. PMID: 30315639 Free PMC article.
-
Ruxolitinib for the treatment of patients with polycythemia vera.Expert Rev Hematol. 2015 Aug;8(4):391-401. doi: 10.1586/17474086.2015.1045869. Epub 2015 May 17. Expert Rev Hematol. 2015. PMID: 25980454 Free PMC article. Review.
-
Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients.BMC Blood Disord. 2010 Dec 22;10:9. doi: 10.1186/1471-2326-10-9. BMC Blood Disord. 2010. PMID: 21176208 Free PMC article.
-
Polycythemia Vera: Barriers to and Strategies for Optimal Management.Blood Lymphat Cancer. 2023 Dec 21;13:77-90. doi: 10.2147/BLCTT.S409443. eCollection 2023. Blood Lymphat Cancer. 2023. PMID: 38146420 Free PMC article. Review.
-
Beyond the Usual Suspects: Hereditary Hemochromatosis and Transaminitis in Primary Care.Cureus. 2023 Aug 14;15(8):e43481. doi: 10.7759/cureus.43481. eCollection 2023 Aug. Cureus. 2023. PMID: 37711943 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical